How big is the atopic dermatitis drugs market?

Atopic dermatitis AD is a pruritic disease of unknown origin that usually starts in early infancy an adultonset variant is recognized.Market Analysis and Insights Global Atopic Dermatitis Drugs MarketDue to the COVID19 pandemic the global Atopic Dermatitis Drugs market size is estimated to be worth US 5694.9 million in 2022 and is forecast to a readjusted size of US 7514.8 million by 2028 with a CAGR of 4.7 during the review period.

BUY CHAPTERS

Atopic Dermatitis Drugs Market Insights, Forecast to 2028

Code: QYRE-Auto-0M10142

Report

March 2022

Pages:87

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

LEO Pharma

Mylan NV

Valeant

Bayer HealthCare

Encore Dermatology

Atopic Dermatitis Drugs Market Outlook - 2028

Due to the COVID-19 pandemic, the global Atopic Dermatitis Drugs market size is estimated to be worth US$ 5694.9 million in 2022 and is forecast to a readjusted size of US$ 7514.8 million by 2028 with a CAGR of 4.7% during the review period.

Atopic Dermatitis Drugs Market

Fully considering the economic change by this health crisis, Injectable accounting for % of the Atopic Dermatitis Drugs global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Hospital segment is altered to an % CAGR throughout this forecast period.

Atopic Dermatitis Drugs Market Insights

One of the major factors responsible for the growing risk of severe atopic dermatitis in infancy is related to food sensitization, which is commonly associated with food allergy. It has been observed that these allergies mainly result from the cow’s milk, chicken eggs, peanuts, wheat, soy, nuts, and fish.

Atopic Dermatitis Drugs Market Scope and Segment

Atopic Dermatitis Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Atopic Dermatitis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Injectable
Oral
Tropical

Segment by Application

Hospital
Clinic

By Company

LEO Pharma
Mylan
Valeant
Bayer HealthCare
Encore Dermatology

By Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

1 Study Coverage

1.1 Atopic Dermatitis Drugs Product Introduction

1.2 Market by Type

1.2.1 Global Atopic Dermatitis Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Injectable

1.2.3 Oral

1.2.4 Tropical

1.3 Market by Application

1.3.1 Global Atopic Dermatitis Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hospital

1.3.3 Clinic

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Atopic Dermatitis Drugs Sales Estimates and Forecasts 2017-2028

2.2 Global Atopic Dermatitis Drugs Revenue Estimates and Forecasts 2017-2028

2.3 Global Atopic Dermatitis Drugs Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Atopic Dermatitis Drugs Sales by Region

2.4.1 Global Atopic Dermatitis Drugs Sales by Region (2017-2022)

2.4.2 Global Sales Atopic Dermatitis Drugs by Region (2023-2028)

2.5 Global Atopic Dermatitis Drugs Revenue by Region

2.5.1 Global Atopic Dermatitis Drugs Revenue by Region (2017-2022)

2.5.2 Global Atopic Dermatitis Drugs Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Atopic Dermatitis Drugs Sales by Manufacturers

3.1.1 Global Top Atopic Dermatitis Drugs Manufacturers by Sales (2017-2022)

3.1.2 Global Atopic Dermatitis Drugs Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Atopic Dermatitis Drugs in 2021

3.2 Global Atopic Dermatitis Drugs Revenue by Manufacturers

3.2.1 Global Atopic Dermatitis Drugs Revenue by Manufacturers (2017-2022)

3.2.2 Global Atopic Dermatitis Drugs Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Atopic Dermatitis Drugs Revenue in 2021

3.3 Global Atopic Dermatitis Drugs Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Atopic Dermatitis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Atopic Dermatitis Drugs Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Atopic Dermatitis Drugs Sales by Type

4.1.1 Global Atopic Dermatitis Drugs Historical Sales by Type (2017-2022)

4.1.2 Global Atopic Dermatitis Drugs Forecasted Sales by Type (2023-2028)

4.1.3 Global Atopic Dermatitis Drugs Sales Market Share by Type (2017-2028)

4.2 Global Atopic Dermatitis Drugs Revenue by Type

4.2.1 Global Atopic Dermatitis Drugs Historical Revenue by Type (2017-2022)

4.2.2 Global Atopic Dermatitis Drugs Forecasted Revenue by Type (2023-2028)

4.2.3 Global Atopic Dermatitis Drugs Revenue Market Share by Type (2017-2028)

4.3 Global Atopic Dermatitis Drugs Price by Type

4.3.1 Global Atopic Dermatitis Drugs Price by Type (2017-2022)

4.3.2 Global Atopic Dermatitis Drugs Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Atopic Dermatitis Drugs Sales by Application

5.1.1 Global Atopic Dermatitis Drugs Historical Sales by Application (2017-2022)

5.1.2 Global Atopic Dermatitis Drugs Forecasted Sales by Application (2023-2028)

5.1.3 Global Atopic Dermatitis Drugs Sales Market Share by Application (2017-2028)

5.2 Global Atopic Dermatitis Drugs Revenue by Application

5.2.1 Global Atopic Dermatitis Drugs Historical Revenue by Application (2017-2022)

5.2.2 Global Atopic Dermatitis Drugs Forecasted Revenue by Application (2023-2028)

5.2.3 Global Atopic Dermatitis Drugs Revenue Market Share by Application (2017-2028)

5.3 Global Atopic Dermatitis Drugs Price by Application

5.3.1 Global Atopic Dermatitis Drugs Price by Application (2017-2022)

5.3.2 Global Atopic Dermatitis Drugs Price Forecast by Application (2023-2028)

6 North America

6.1 North America Atopic Dermatitis Drugs Market Size by Type

6.1.1 North America Atopic Dermatitis Drugs Sales by Type (2017-2028)

6.1.2 North America Atopic Dermatitis Drugs Revenue by Type (2017-2028)

6.2 North America Atopic Dermatitis Drugs Market Size by Application

6.2.1 North America Atopic Dermatitis Drugs Sales by Application (2017-2028)

6.2.2 North America Atopic Dermatitis Drugs Revenue by Application (2017-2028)

6.3 North America Atopic Dermatitis Drugs Market Size by Country

6.3.1 North America Atopic Dermatitis Drugs Sales by Country (2017-2028)

6.3.2 North America Atopic Dermatitis Drugs Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Atopic Dermatitis Drugs Market Size by Type

7.1.1 Europe Atopic Dermatitis Drugs Sales by Type (2017-2028)

7.1.2 Europe Atopic Dermatitis Drugs Revenue by Type (2017-2028)

7.2 Europe Atopic Dermatitis Drugs Market Size by Application

7.2.1 Europe Atopic Dermatitis Drugs Sales by Application (2017-2028)

7.2.2 Europe Atopic Dermatitis Drugs Revenue by Application (2017-2028)

7.3 Europe Atopic Dermatitis Drugs Market Size by Country

7.3.1 Europe Atopic Dermatitis Drugs Sales by Country (2017-2028)

7.3.2 Europe Atopic Dermatitis Drugs Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Atopic Dermatitis Drugs Market Size by Type

8.1.1 Asia Pacific Atopic Dermatitis Drugs Sales by Type (2017-2028)

8.1.2 Asia Pacific Atopic Dermatitis Drugs Revenue by Type (2017-2028)

8.2 Asia Pacific Atopic Dermatitis Drugs Market Size by Application

8.2.1 Asia Pacific Atopic Dermatitis Drugs Sales by Application (2017-2028)

8.2.2 Asia Pacific Atopic Dermatitis Drugs Revenue by Application (2017-2028)

8.3 Asia Pacific Atopic Dermatitis Drugs Market Size by Region

8.3.1 Asia Pacific Atopic Dermatitis Drugs Sales by Region (2017-2028)

8.3.2 Asia Pacific Atopic Dermatitis Drugs Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

8.3.12 Philippines

9 Latin America

9.1 Latin America Atopic Dermatitis Drugs Market Size by Type

9.1.1 Latin America Atopic Dermatitis Drugs Sales by Type (2017-2028)

9.1.2 Latin America Atopic Dermatitis Drugs Revenue by Type (2017-2028)

9.2 Latin America Atopic Dermatitis Drugs Market Size by Application

9.2.1 Latin America Atopic Dermatitis Drugs Sales by Application (2017-2028)

9.2.2 Latin America Atopic Dermatitis Drugs Revenue by Application (2017-2028)

9.3 Latin America Atopic Dermatitis Drugs Market Size by Country

9.3.1 Latin America Atopic Dermatitis Drugs Sales by Country (2017-2028)

9.3.2 Latin America Atopic Dermatitis Drugs Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Atopic Dermatitis Drugs Market Size by Type

10.1.1 Middle East and Africa Atopic Dermatitis Drugs Sales by Type (2017-2028)

10.1.2 Middle East and Africa Atopic Dermatitis Drugs Revenue by Type (2017-2028)

10.2 Middle East and Africa Atopic Dermatitis Drugs Market Size by Application

10.2.1 Middle East and Africa Atopic Dermatitis Drugs Sales by Application (2017-2028)

10.2.2 Middle East and Africa Atopic Dermatitis Drugs Revenue by Application (2017-2028)

10.3 Middle East and Africa Atopic Dermatitis Drugs Market Size by Country

10.3.1 Middle East and Africa Atopic Dermatitis Drugs Sales by Country (2017-2028)

10.3.2 Middle East and Africa Atopic Dermatitis Drugs Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 LEO Pharma

11.1.1 LEO Pharma Corporation Information

11.1.2 LEO Pharma Overview

11.1.3 LEO Pharma Atopic Dermatitis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 LEO Pharma Atopic Dermatitis Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 LEO Pharma Recent Developments

11.2 Mylan

11.2.1 Mylan Corporation Information

11.2.2 Mylan Overview

11.2.3 Mylan Atopic Dermatitis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.2.4 Mylan Atopic Dermatitis Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Mylan Recent Developments

11.3 Valeant

11.3.1 Valeant Corporation Information

11.3.2 Valeant Overview

11.3.3 Valeant Atopic Dermatitis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.3.4 Valeant Atopic Dermatitis Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Valeant Recent Developments

11.4 Bayer HealthCare

11.4.1 Bayer HealthCare Corporation Information

11.4.2 Bayer HealthCare Overview

11.4.3 Bayer HealthCare Atopic Dermatitis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.4.4 Bayer HealthCare Atopic Dermatitis Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 Bayer HealthCare Recent Developments

11.5 Encore Dermatology

11.5.1 Encore Dermatology Corporation Information

11.5.2 Encore Dermatology Overview

11.5.3 Encore Dermatology Atopic Dermatitis Drugs Sales, Price, Revenue and Gross Margin (2017-2022)

11.5.4 Encore Dermatology Atopic Dermatitis Drugs Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Encore Dermatology Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Atopic Dermatitis Drugs Industry Chain Analysis

12.2 Atopic Dermatitis Drugs Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Atopic Dermatitis Drugs Production Mode & Process

12.4 Atopic Dermatitis Drugs Sales and Marketing

12.4.1 Atopic Dermatitis Drugs Sales Channels

12.4.2 Atopic Dermatitis Drugs Distributors

12.5 Atopic Dermatitis Drugs Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Atopic Dermatitis Drugs Industry Trends

13.2 Atopic Dermatitis Drugs Market Drivers

13.3 Atopic Dermatitis Drugs Market Challenges

13.4 Atopic Dermatitis Drugs Market Restraints

14 Key Findings in The Global Atopic Dermatitis Drugs Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

FEATURED COMPANIES

LEO Pharma

Mylan NV

Valeant

Bayer HealthCare

Encore Dermatology

List of Tables

Table 1. Global Atopic Dermatitis Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)

Table 2. Major Manufacturers of Injectable

Table 3. Major Manufacturers of Oral

Table 4. Major Manufacturers of Tropical

Table 5. Global Atopic Dermatitis Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)

Table 6. Global Atopic Dermatitis Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)

Table 7. Global Atopic Dermatitis Drugs Sales by Region (2017-2022) & (K Units)

Table 8. Global Atopic Dermatitis Drugs Sales Market Share by Region (2017-2022)

Table 9. Global Atopic Dermatitis Drugs Sales by Region (2023-2028) & (K Units)

Table 10. Global Atopic Dermatitis Drugs Sales Market Share by Region (2023-2028)

Table 11. Global Atopic Dermatitis Drugs Revenue by Region (2017-2022) & (US$ Million)

Table 12. Global Atopic Dermatitis Drugs Revenue Market Share by Region (2017-2022)

Table 13. Global Atopic Dermatitis Drugs Revenue by Region (2023-2028) & (US$ Million)

Table 14. Global Atopic Dermatitis Drugs Revenue Market Share by Region (2023-2028)

Table 15. Global Atopic Dermatitis Drugs Sales by Manufacturers (2017-2022) & (K Units)

Table 16. Global Atopic Dermatitis Drugs Sales Share by Manufacturers (2017-2022)

Table 17. Global Atopic Dermatitis Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)

Table 18. Global Atopic Dermatitis Drugs Revenue Share by Manufacturers (2017-2022)

Table 19. Atopic Dermatitis Drugs Price by Manufacturers (2017-2022) &(USD/Unit)

Table 20. Global Atopic Dermatitis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 21. Global Atopic Dermatitis Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Atopic Dermatitis Drugs as of 2021)

Table 22. Atopic Dermatitis Drugs Manufacturing Base Distribution and Headquarters

Table 23. Manufacturers Atopic Dermatitis Drugs Product Offered

Table 24. Date of Manufacturers Enter into Atopic Dermatitis Drugs Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Atopic Dermatitis Drugs Sales by Type (2017-2022) & (K Units)

Table 27. Global Atopic Dermatitis Drugs Sales by Type (2023-2028) & (K Units)

Table 28. Global Atopic Dermatitis Drugs Sales Share by Type (2017-2022)

Table 29. Global Atopic Dermatitis Drugs Sales Share by Type (2023-2028)

Table 30. Global Atopic Dermatitis Drugs Revenue by Type (2017-2022) & (US$ Million)

Table 31. Global Atopic Dermatitis Drugs Revenue by Type (2023-2028) & (US$ Million)

Table 32. Global Atopic Dermatitis Drugs Revenue Share by Type (2017-2022)

Table 33. Global Atopic Dermatitis Drugs Revenue Share by Type (2023-2028)

Table 34. Atopic Dermatitis Drugs Price by Type (2017-2022) & (USD/Unit)

Table 35. Global Atopic Dermatitis Drugs Price Forecast by Type (2023-2028) & (USD/Unit)

Table 36. Global Atopic Dermatitis Drugs Sales by Application (2017-2022) & (K Units)

Table 37. Global Atopic Dermatitis Drugs Sales by Application (2023-2028) & (K Units)

Table 38. Global Atopic Dermatitis Drugs Sales Share by Application (2017-2022)

Table 39. Global Atopic Dermatitis Drugs Sales Share by Application (2023-2028)

Table 40. Global Atopic Dermatitis Drugs Revenue by Application (2017-2022) & (US$ Million)

Table 41. Global Atopic Dermatitis Drugs Revenue by Application (2023-2028) & (US$ Million)

Table 42. Global Atopic Dermatitis Drugs Revenue Share by Application (2017-2022)

Table 43. Global Atopic Dermatitis Drugs Revenue Share by Application (2023-2028)

Table 44. Atopic Dermatitis Drugs Price by Application (2017-2022) & (USD/Unit)

Table 45. Global Atopic Dermatitis Drugs Price Forecast by Application (2023-2028) & (USD/Unit)

Table 46. North America Atopic Dermatitis Drugs Sales by Type (2017-2022) & (K Units)

Table 47. North America Atopic Dermatitis Drugs Sales by Type (2023-2028) & (K Units)

Table 48. North America Atopic Dermatitis Drugs Revenue by Type (2017-2022) & (US$ Million)

Table 49. North America Atopic Dermatitis Drugs Revenue by Type (2023-2028) & (US$ Million)

Table 50. North America Atopic Dermatitis Drugs Sales by Application (2017-2022) & (K Units)

Table 51. North America Atopic Dermatitis Drugs Sales by Application (2023-2028) & (K Units)

Table 52. North America Atopic Dermatitis Drugs Revenue by Application (2017-2022) & (US$ Million)

Table 53. North America Atopic Dermatitis Drugs Revenue by Application (2023-2028) & (US$ Million)

Table 54. North America Atopic Dermatitis Drugs Sales by Country (2017-2022) & (K Units)

Table 55. North America Atopic Dermatitis Drugs Sales by Country (2023-2028) & (K Units)

Table 56. North America Atopic Dermatitis Drugs Revenue by Country (2017-2022) & (US$ Million)

Table 57. North America Atopic Dermatitis Drugs Revenue by Country (2023-2028) & (US$ Million)

Table 58. Europe Atopic Dermatitis Drugs Sales by Type (2017-2022) & (K Units)

Table 59. Europe Atopic Dermatitis Drugs Sales by Type (2023-2028) & (K Units)

Table 60. Europe Atopic Dermatitis Drugs Revenue by Type (2017-2022) & (US$ Million)

Table 61. Europe Atopic Dermatitis Drugs Revenue by Type (2023-2028) & (US$ Million)

Table 62. Europe Atopic Dermatitis Drugs Sales by Application (2017-2022) & (K Units)

Table 63. Europe Atopic Dermatitis Drugs Sales by Application (2023-2028) & (K Units)

Table 64. Europe Atopic Dermatitis Drugs Revenue by Application (2017-2022) & (US$ Million)

Table 65. Europe Atopic Dermatitis Drugs Revenue by Application (2023-2028) & (US$ Million)

Table 66. Europe Atopic Dermatitis Drugs Sales by Country (2017-2022) & (K Units)

Table 67. Europe Atopic Dermatitis Drugs Sales by Country (2023-2028) & (K Units)

Table 68. Europe Atopic Dermatitis Drugs Revenue by Country (2017-2022) & (US$ Million)

Table 69. Europe Atopic Dermatitis Drugs Revenue by Country (2023-2028) & (US$ Million)

Table 70. Asia Pacific Atopic Dermatitis Drugs Sales by Type (2017-2022) & (K Units)

Table 71. Asia Pacific Atopic Dermatitis Drugs Sales by Type (2023-2028) & (K Units)

Table 72. Asia Pacific Atopic Dermatitis Drugs Revenue by Type (2017-2022) & (US$ Million)

Table 73. Asia Pacific Atopic Dermatitis Drugs Revenue by Type (2023-2028) & (US$ Million)

Table 74. Asia Pacific Atopic Dermatitis Drugs Sales by Application (2017-2022) & (K Units)

Table 75. Asia Pacific Atopic Dermatitis Drugs Sales by Application (2023-2028) & (K Units)

Table 76. Asia Pacific Atopic Dermatitis Drugs Revenue by Application (2017-2022) & (US$ Million)

Table 77. Asia Pacific Atopic Dermatitis Drugs Revenue by Application (2023-2028) & (US$ Million)

Table 78. Asia Pacific Atopic Dermatitis Drugs Sales by Region (2017-2022) & (K Units)

Table 79. Asia Pacific Atopic Dermatitis Drugs Sales by Region (2023-2028) & (K Units)

Table 80. Asia Pacific Atopic Dermatitis Drugs Revenue by Region (2017-2022) & (US$ Million)

Table 81. Asia Pacific Atopic Dermatitis Drugs Revenue by Region (2023-2028) & (US$ Million)

Table 82. Latin America Atopic Dermatitis Drugs Sales by Type (2017-2022) & (K Units)

Table 83. Latin America Atopic Dermatitis Drugs Sales by Type (2023-2028) & (K Units)

Table 84. Latin America Atopic Dermatitis Drugs Revenue by Type (2017-2022) & (US$ Million)

Table 85. Latin America Atopic Dermatitis Drugs Revenue by Type (2023-2028) & (US$ Million)

Table 86. Latin America Atopic Dermatitis Drugs Sales by Application (2017-2022) & (K Units)

Table 87. Latin America Atopic Dermatitis Drugs Sales by Application (2023-2028) & (K Units)

Table 88. Latin America Atopic Dermatitis Drugs Revenue by Application (2017-2022) & (US$ Million)

Table 89. Latin America Atopic Dermatitis Drugs Revenue by Application (2023-2028) & (US$ Million)

Table 90. Latin America Atopic Dermatitis Drugs Sales by Country (2017-2022) & (K Units)

Table 91. Latin America Atopic Dermatitis Drugs Sales by Country (2023-2028) & (K Units)

Table 92. Latin America Atopic Dermatitis Drugs Revenue by Country (2017-2022) & (US$ Million)

Table 93. Latin America Atopic Dermatitis Drugs Revenue by Country (2023-2028) & (US$ Million)

Table 94. Middle East and Africa Atopic Dermatitis Drugs Sales by Type (2017-2022) & (K Units)

Table 95. Middle East and Africa Atopic Dermatitis Drugs Sales by Type (2023-2028) & (K Units)

Table 96. Middle East and Africa Atopic Dermatitis Drugs Revenue by Type (2017-2022) & (US$ Million)

Table 97. Middle East and Africa Atopic Dermatitis Drugs Revenue by Type (2023-2028) & (US$ Million)

Table 98. Middle East and Africa Atopic Dermatitis Drugs Sales by Application (2017-2022) & (K Units)

Table 99. Middle East and Africa Atopic Dermatitis Drugs Sales by Application (2023-2028) & (K Units)

Table 100. Middle East and Africa Atopic Dermatitis Drugs Revenue by Application (2017-2022) & (US$ Million)

Table 101. Middle East and Africa Atopic Dermatitis Drugs Revenue by Application (2023-2028) & (US$ Million)

Table 102. Middle East and Africa Atopic Dermatitis Drugs Sales by Country (2017-2022) & (K Units)

Table 103. Middle East and Africa Atopic Dermatitis Drugs Sales by Country (2023-2028) & (K Units)

Table 104. Middle East and Africa Atopic Dermatitis Drugs Revenue by Country (2017-2022) & (US$ Million)

Table 105. Middle East and Africa Atopic Dermatitis Drugs Revenue by Country (2023-2028) & (US$ Million)

Table 106. LEO Pharma Corporation Information

Table 107. LEO Pharma Description and Major Businesses

Table 108. LEO Pharma Atopic Dermatitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 109. LEO Pharma Atopic Dermatitis Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 110. LEO Pharma Recent Developments

Table 111. Mylan Corporation Information

Table 112. Mylan Description and Major Businesses

Table 113. Mylan Atopic Dermatitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 114. Mylan Atopic Dermatitis Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 115. Mylan Recent Developments

Table 116. Valeant Corporation Information

Table 117. Valeant Description and Major Businesses

Table 118. Valeant Atopic Dermatitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 119. Valeant Atopic Dermatitis Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 120. Valeant Recent Developments

Table 121. Bayer HealthCare Corporation Information

Table 122. Bayer HealthCare Description and Major Businesses

Table 123. Bayer HealthCare Atopic Dermatitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 124. Bayer HealthCare Atopic Dermatitis Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 125. Bayer HealthCare Recent Developments

Table 126. Encore Dermatology Corporation Information

Table 127. Encore Dermatology Description and Major Businesses

Table 128. Encore Dermatology Atopic Dermatitis Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)

Table 129. Encore Dermatology Atopic Dermatitis Drugs Product Model Numbers, Pictures, Descriptions and Specifications

Table 130. Encore Dermatology Recent Developments

Table 131. Key Raw Materials Lists

Table 132. Raw Materials Key Suppliers Lists

Table 133. Atopic Dermatitis Drugs Distributors List

Table 134. Atopic Dermatitis Drugs Customers List

Table 135. Atopic Dermatitis Drugs Market Trends

Table 136. Atopic Dermatitis Drugs Market Drivers

Table 137. Atopic Dermatitis Drugs Market Challenges

Table 138. Atopic Dermatitis Drugs Market Restraints

Table 139. Research Programs/Design for This Report

Table 140. Key Data Information from Secondary Sources

Table 141. Key Data Information from Primary Sources

List of Figures

Figure 1. Atopic Dermatitis Drugs Product Picture

Figure 3. Global Atopic Dermatitis Drugs Market Share by Type in 2021 & 2028

Figure 3. Injectable Product Picture

Figure 4. Oral Product Picture

Figure 5. Tropical Product Picture

Figure 6. Global Atopic Dermatitis Drugs Market Share by Application in 2021 & 2028

Figure 7. Hospital

Figure 8. Clinic

Figure 9. Atopic Dermatitis Drugs Report Years Considered

Figure 10. Global Atopic Dermatitis Drugs Sales 2017-2028 (K Units)

Figure 11. Global Atopic Dermatitis Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 12. Global Atopic Dermatitis Drugs Revenue 2017-2028 (US$ Million)

Figure 13. Global Atopic Dermatitis Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028

Figure 14. Global Atopic Dermatitis Drugs Sales Market Share by Region (2017-2022)

Figure 15. Global Atopic Dermatitis Drugs Sales Market Share by Region (2023-2028)

Figure 16. North America Atopic Dermatitis Drugs Sales YoY (2017-2028) & (K Units)

Figure 17. North America Atopic Dermatitis Drugs Revenue YoY (2017-2028) & (US$ Million)

Figure 18. Europe Atopic Dermatitis Drugs Sales YoY (2017-2028) & (K Units)

Figure 19. Europe Atopic Dermatitis Drugs Revenue YoY (2017-2028) & (US$ Million)

Figure 20. Asia-Pacific Atopic Dermatitis Drugs Sales YoY (2017-2028) & (K Units)

Figure 21. Asia-Pacific Atopic Dermatitis Drugs Revenue YoY (2017-2028) & (US$ Million)

Figure 22. Latin America Atopic Dermatitis Drugs Sales YoY (2017-2028) & (K Units)

Figure 23. Latin America Atopic Dermatitis Drugs Revenue YoY (2017-2028) & (US$ Million)

Figure 24. Middle East & Africa Atopic Dermatitis Drugs Sales YoY (2017-2028) & (K Units)

Figure 25. Middle East & Africa Atopic Dermatitis Drugs Revenue YoY (2017-2028) & (US$ Million)

Figure 26. The Atopic Dermatitis Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021

Figure 27. The Top 5 and 10 Largest Manufacturers of Atopic Dermatitis Drugs in the World: Market Share by Atopic Dermatitis Drugs Revenue in 2021

Figure 28. Global Atopic Dermatitis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021

Figure 29. Global Atopic Dermatitis Drugs Sales Market Share by Type (2017-2028)

Figure 30. Global Atopic Dermatitis Drugs Revenue Market Share by Type (2017-2028)

Figure 31. Global Atopic Dermatitis Drugs Sales Market Share by Application (2017-2028)

Figure 32. Global Atopic Dermatitis Drugs Revenue Market Share by Application (2017-2028)

Figure 33. North America Atopic Dermatitis Drugs Sales Market Share by Type (2017-2028)

Figure 34. North America Atopic Dermatitis Drugs Revenue Market Share by Type (2017-2028)

Figure 35. North America Atopic Dermatitis Drugs Sales Market Share by Application (2017-2028)

Figure 36. North America Atopic Dermatitis Drugs Revenue Market Share by Application (2017-2028)

Figure 37. North America Atopic Dermatitis Drugs Sales Share by Country (2017-2028)

Figure 38. North America Atopic Dermatitis Drugs Revenue Share by Country (2017-2028)

Figure 39. U.S. Atopic Dermatitis Drugs Revenue (2017-2028) & (US$ Million)

Figure 40. Canada Atopic Dermatitis Drugs Revenue (2017-2028) & (US$ Million)

Figure 41. Europe Atopic Dermatitis Drugs Sales Market Share by Type (2017-2028)

Figure 42. Europe Atopic Dermatitis Drugs Revenue Market Share by Type (2017-2028)

Figure 43. Europe Atopic Dermatitis Drugs Sales Market Share by Application (2017-2028)

Figure 44. Europe Atopic Dermatitis Drugs Revenue Market Share by Application (2017-2028)

Figure 45. Europe Atopic Dermatitis Drugs Sales Share by Country (2017-2028)

Figure 46. Europe Atopic Dermatitis Drugs Revenue Share by Country (2017-2028)

Figure 47. Germany Atopic Dermatitis Drugs Revenue (2017-2028) & (US$ Million)

Figure 48. France Atopic Dermatitis Drugs Revenue (2017-2028) & (US$ Million)

Figure 49. U.K. Atopic Dermatitis Drugs Revenue (2017-2028) & (US$ Million)

Figure 50. Italy Atopic Dermatitis Drugs Revenue (2017-2028) & (US$ Million)

Figure 51. Russia Atopic Dermatitis Drugs Revenue (2017-2028) & (US$ Million)

Figure 52. Asia Pacific Atopic Dermatitis Drugs Sales Market Share by Type (2017-2028)

Figure 53. Asia Pacific Atopic Dermatitis Drugs Revenue Market Share by Type (2017-2028)

Figure 54. Asia Pacific Atopic Dermatitis Drugs Sales Market Share by Application (2017-2028)

Figure 55. Asia Pacific Atopic Dermatitis Drugs Revenue Market Share by Application (2017-2028)

Figure 56. Asia Pacific Atopic Dermatitis Drugs Sales Share by Region (2017-2028)

Figure 57. Asia Pacific Atopic Dermatitis Drugs Revenue Share by Region (2017-2028)

Figure 58. China Atopic Dermatitis Drugs Revenue (2017-2028) & (US$ Million)

Figure 59. Japan Atopic Dermatitis Drugs Revenue (2017-2028) & (US$ Million)

Figure 60. South Korea Atopic Dermatitis Drugs Revenue (2017-2028) & (US$ Million)

Figure 61. India Atopic Dermatitis Drugs Revenue (2017-2028) & (US$ Million)

Figure 62. Australia Atopic Dermatitis Drugs Revenue (2017-2028) & (US$ Million)

Figure 63. Taiwan Atopic Dermatitis Drugs Revenue (2017-2028) & (US$ Million)

Figure 64. Indonesia Atopic Dermatitis Drugs Revenue (2017-2028) & (US$ Million)

Figure 65. Thailand Atopic Dermatitis Drugs Revenue (2017-2028) & (US$ Million)

Figure 66. Malaysia Atopic Dermatitis Drugs Revenue (2017-2028) & (US$ Million)

Figure 67. Philippines Atopic Dermatitis Drugs Revenue (2017-2028) & (US$ Million)

Figure 68. Latin America Atopic Dermatitis Drugs Sales Market Share by Type (2017-2028)

Figure 69. Latin America Atopic Dermatitis Drugs Revenue Market Share by Type (2017-2028)

Figure 70. Latin America Atopic Dermatitis Drugs Sales Market Share by Application (2017-2028)

Figure 71. Latin America Atopic Dermatitis Drugs Revenue Market Share by Application (2017-2028)

Figure 72. Latin America Atopic Dermatitis Drugs Sales Share by Country (2017-2028)

Figure 73. Latin America Atopic Dermatitis Drugs Revenue Share by Country (2017-2028)

Figure 74. Mexico Atopic Dermatitis Drugs Revenue (2017-2028) & (US$ Million)

Figure 75. Brazil Atopic Dermatitis Drugs Revenue (2017-2028) & (US$ Million)

Figure 76. Argentina Atopic Dermatitis Drugs Revenue (2017-2028) & (US$ Million)

Figure 77. Middle East and Africa Atopic Dermatitis Drugs Sales Market Share by Type (2017-2028)

Figure 78. Middle East and Africa Atopic Dermatitis Drugs Revenue Market Share by Type (2017-2028)

Figure 79. Middle East and Africa Atopic Dermatitis Drugs Sales Market Share by Application (2017-2028)

Figure 80. Middle East and Africa Atopic Dermatitis Drugs Revenue Market Share by Application (2017-2028)

Figure 81. Middle East and Africa Atopic Dermatitis Drugs Sales Share by Country (2017-2028)

Figure 82. Middle East and Africa Atopic Dermatitis Drugs Revenue Share by Country (2017-2028)

Figure 83. Turkey Atopic Dermatitis Drugs Revenue (2017-2028) & (US$ Million)

Figure 84. Saudi Arabia Atopic Dermatitis Drugs Revenue (2017-2028) & (US$ Million)

Figure 85. U.A.E Atopic Dermatitis Drugs Revenue (2017-2028) & (US$ Million)

Figure 86. Atopic Dermatitis Drugs Value Chain

Figure 87. Atopic Dermatitis Drugs Production Process

Figure 88. Channels of Distribution

Figure 89. Distributors Profiles

Figure 90. Bottom-up and Top-down Approaches for This Report

Figure 91. Data Triangulation

Figure 92. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Atopic Dermatitis Drugs Market Insights, Forecast to 2028

Published Date: March 2022

Report Code: QYRE-Auto-0M10142

Atopic Dermatitis Drugs Market Insights, Forecast to 2028

FEATURED COMPANIES

Atopic Dermatitis Drugs Market Outlook - 2028

Atopic Dermatitis Drugs Market Insights

Atopic Dermatitis Drugs Market Scope and Segment

Segment by Type

Segment by Application

By Company

By Region

FEATURED COMPANIES

RELATED REPORTS